| Heart Failure (HF) |
1 |
1 |
| Cardiovascular Imaging |
0 |
0.8 |
| Ejection Fraction |
0 |
0.99 |
| Heart |
0 |
0.62 |
| Hypertension |
0 |
0.46 |
| Cardiomyopathy |
0 |
0.44 |
| Cardiovascular Risk Management |
0 |
0.43 |
| Heart Transplantation |
0 |
0.42 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.95 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.21 |
| HIV Infection |
0 |
0.21 |
| ACE Inhibitor |
0 |
0.2 |
| Type 2 Diabetes Mellitus |
0 |
0.19 |
| Receptors |
0 |
0.14 |
| Angiotensin II Receptor Blockade |
0 |
0.13 |
| Beta Blockers |
0 |
0.1 |
| Cardiovascular disease |
0 |
0.05 |
| Clinical Research |
0 |
0.05 |
| Europe |
0 |
0.05 |
| Grant |
0 |
0.05 |
| Hospital |
0 |
0.05 |
| New York |
0 |
0.05 |
| Transplantation |
0 |
0.05 |